2017
DOI: 10.1590/s2175-97902017000116144
|View full text |Cite
|
Sign up to set email alerts
|

Hydrocortisone release from tablets based on bioresorbable poly(ether-ester-urethane)s

Abstract: Bioresorbable linear poly(ether-ester-urethane)s with different hydrophilic characteristics were synthesized from triblock copolymers of poly(ε-caprolactone)-poly(ethylene oxide)-poly(ε-caprolactone) (PCL-PEO) as macrodiols, and L-lysine diisocyanate (LDI) or hexamethylenediisocyanate (HDI) were used as the required diisocyanates. Macrodiols were obtained by ring-opening polymerization (ROP) of ε-caprolactone (CL). Polyurethanes were synthesized by the reaction of the triblock copolymers with LDI or HDI in sol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 28 publications
0
5
0
Order By: Relevance
“…The biocompatible PEO serves as the hydrophilic shell providing stealth properties to the micellar system, preventing its uptake by the reticuloendothelial system (RES) [ 15 ]. To date, several studies have reported the development of PEO-b-PCL polymeric micelles as effective vehicles for the solubilization and delivery of doxorubicin [ 16 ], paclitaxel [ 17 ], curcumin [ 18 , 19 ], indomethacin [ 20 ], camptothecin [ 21 ], tacrolimus [ 22 ], cyclosporine [ 23 ], amiodarone [ 24 ], hydrocortisone [ 25 ], clotrimazole [ 15 ], cucurbitacin [ 26 ], among others.…”
Section: Introductionmentioning
confidence: 99%
“…The biocompatible PEO serves as the hydrophilic shell providing stealth properties to the micellar system, preventing its uptake by the reticuloendothelial system (RES) [ 15 ]. To date, several studies have reported the development of PEO-b-PCL polymeric micelles as effective vehicles for the solubilization and delivery of doxorubicin [ 16 ], paclitaxel [ 17 ], curcumin [ 18 , 19 ], indomethacin [ 20 ], camptothecin [ 21 ], tacrolimus [ 22 ], cyclosporine [ 23 ], amiodarone [ 24 ], hydrocortisone [ 25 ], clotrimazole [ 15 ], cucurbitacin [ 26 ], among others.…”
Section: Introductionmentioning
confidence: 99%
“…Several approaches including chitosan nanoparticles, liposomal gels, nanoemulsions, positively charged nanoemulsions, microemulsions and cyclodextrin solutions were studied successfully for dermal and transdermal drug delivery of HCN. Some polymer‐based tablets and colon targeted tablets have also been investigated for the oral drug delivery of HCN . Recently, the spray dried solid dispersions have also been studied for the oral bioavailability enhancement of HCN .…”
Section: Introductionmentioning
confidence: 99%
“…PEO segments improved biocompatibility and increased drug release in vitro (12). The main release mechanisms of the tablets involved the swelling of the polymer, when in contact with aqueous medium, due to the high hydrophilicity of PEO segments, followed by partial diffusion of the drug through the swollen matrix, and finally, polymer erosion and drug release (2).…”
Section: Introductionmentioning
confidence: 99%
“…Polyurethanes (PU) compose a very versatile class of materials, possibly being tailor-made with biocompatible characteristics to biological systems, such as blood, organs and organic tissues and biodegradability (1)(2)(3). The properties of those systems differ greatly depending on the composition and stoichiometry of monomers (4,5).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation